BEIJING (Reuters): Chinese vaccine maker Sinovac Biotech plans to start a clinical trial of its experimental coronavirus vaccine with children and adolescents later this month, widening its test on a shot that's already in the final stage of study with adults.
Finding a vaccine that works for the entire population, including younger people, could be crucial to preventing outbreaks of the virus -- that has led to over 930,000 deaths worldwide -- through schools and kindergartens, potentially affecting also teachers and parents.